HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Raffaele Porrini Selected Research

Therapeutics

3/2016Spleen enlargement is a risk factor for thrombosis in essential thrombocythemia: Evaluation on 1,297 patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Raffaele Porrini Research Topics

Disease

4Neoplasms (Cancer)
01/2022 - 01/2012
2Primary Myelofibrosis (Myelosclerosis)
01/2022 - 03/2015
2BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2016 - 06/2011
1Iron Overload
01/2022
1Essential Thrombocythemia
09/2020
1Splenomegaly
03/2016
1Thrombosis (Thrombus)
03/2016
1Philadelphia Chromosome
01/2012

Drug/Important Bio-Agent (IBA)

2DeferasiroxFDA Link
01/2022 - 06/2016
1ruxolitinibIBA
01/2022
1anagrelide (Agrylin)FDA LinkGeneric
09/2020
1amsonic acid (DAS)IBA
01/2016
1Dasatinib (BMS 354825)FDA Link
01/2016
1Hemoglobins (Hemoglobin)IBA
03/2015
1Hydroxyurea (Hydrea)FDA LinkGeneric
01/2012
1Tyrosine Kinase InhibitorsIBA
06/2011

Therapy/Procedure

1Therapeutics
03/2016